首站-论文投稿智能助手
典型文献
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
文献摘要:
Immune checkpoint blockade (ICB) therapy has recently shown promise in treating several malignancies. However, only a limited number of patients respond to this treatment, partially because of the "immune cold" condition of the tumor immune microenvironment. Pyroptosis is a type of gasdermin-mediated programmed cell death that often leads to inflammation and immune responses. Many studies on the mechanism and function of pyroptosis have led to increasing recognition of the role of pyroptosis in malignant progression and immune therapy. Pyroptosis has the potential to alter the tumor immune microenvironment by releasing tumor-associated antigens, damage-associated molecular patterns, and proinflammatory cytokines, thus leading to intratumoral inflammatory responses, stimulation of tumor-specific cytotoxic T cell infiltration, conversion of "cold" to "hot" tumors, and ultimately improving the efficacy of ICB therapy. Some cancer treatments have been shown to restore anticancer immunosurveillance through the induction of pyroptosis. Therapy promoting pyroptosis and ICB therapy may have synergistic effects in cancer treatment. This review summarizes the mechanisms and roles of pyroptosis in the tumor microenvironment and combination treatment strategies. An improved understanding of the roles of pyroptosis in tumorigenesis, immune evasion, and treatment would aid in the development of therapeutic strategies for malignancies.
文献关键词:
作者姓名:
Wuyin Wang;Lu Zhang;Zhijun Sun
作者机构:
The State Key Laboratory Breeding Base of Basic Science of Stomatology(Hubei-MOST)&Key Laboratory of Oral Biomedicine Ministry of Education,School&Hospital of Stomatology,Wuhan University,Wuhan 430079,China;Department of Oral Maxillofacial-Head Neck Oncology,School&Hospital of Stomatology,Wuhan University,Wuhan 430079,China
引用格式:
[1]Wuyin Wang;Lu Zhang;Zhijun Sun-.Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies)[J].癌症生物学与医学(英文版),2022(07):948-964
A类:
Eliciting,immunosurveillance
B类:
pyroptosis,fuel,immunotherapy,mechanisms,strategies,Immune,checkpoint,blockade,ICB,has,recently,shown,promise,treating,several,malignancies,However,only,limited,number,patients,respond,this,partially,because,immune,cold,condition,microenvironment,Pyroptosis,type,gasdermin,mediated,programmed,cell,death,that,often,leads,inflammation,responses,Many,studies,function,have,led,increasing,recognition,malignant,progression,potential,alter,by,releasing,associated,antigens,damage,molecular,patterns,proinflammatory,cytokines,thus,leading,intratumoral,stimulation,specific,cytotoxic,infiltration,conversion,hot,tumors,ultimately,improving,efficacy,Some,treatments,been,restore,anticancer,through,induction,Therapy,promoting,may,synergistic,effects,This,review,summarizes,roles,combination,An,improved,understanding,tumorigenesis,evasion,would,aid,development,therapeutic
AB值:
0.580788
相似文献
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。